JP6324395B2 - 軟骨細胞を移植する方法 - Google Patents

軟骨細胞を移植する方法 Download PDF

Info

Publication number
JP6324395B2
JP6324395B2 JP2015539923A JP2015539923A JP6324395B2 JP 6324395 B2 JP6324395 B2 JP 6324395B2 JP 2015539923 A JP2015539923 A JP 2015539923A JP 2015539923 A JP2015539923 A JP 2015539923A JP 6324395 B2 JP6324395 B2 JP 6324395B2
Authority
JP
Japan
Prior art keywords
cartilage
cells
derived
chondrocytes
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015539923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015534809A (ja
JP2015534809A5 (OSRAM
Inventor
ディリーマ，ダリル，ディー．
オリー，ツァイウェイ
コールウェル，クリフォード，ダブリュ．
Original Assignee
スクリップス ヘルス
スクリップス ヘルス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スクリップス ヘルス, スクリップス ヘルス filed Critical スクリップス ヘルス
Publication of JP2015534809A publication Critical patent/JP2015534809A/ja
Publication of JP2015534809A5 publication Critical patent/JP2015534809A5/ja
Application granted granted Critical
Publication of JP6324395B2 publication Critical patent/JP6324395B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015539923A 2012-10-29 2013-10-29 軟骨細胞を移植する方法 Active JP6324395B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261719902P 2012-10-29 2012-10-29
US61/719,902 2012-10-29
PCT/US2013/067349 WO2014070796A1 (en) 2012-10-29 2013-10-29 Methods of transplanting chondrocytes

Publications (3)

Publication Number Publication Date
JP2015534809A JP2015534809A (ja) 2015-12-07
JP2015534809A5 JP2015534809A5 (OSRAM) 2016-11-10
JP6324395B2 true JP6324395B2 (ja) 2018-05-16

Family

ID=50628009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015539923A Active JP6324395B2 (ja) 2012-10-29 2013-10-29 軟骨細胞を移植する方法

Country Status (4)

Country Link
US (3) US9974885B2 (OSRAM)
EP (1) EP2911709B1 (OSRAM)
JP (1) JP6324395B2 (OSRAM)
WO (1) WO2014070796A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10724005B2 (en) 2012-09-28 2020-07-28 Scripps Health Methods of differentiating stem cells into chondrocytes
WO2014070797A1 (en) 2012-10-29 2014-05-08 Scripps Health Methods of producing pluripotent stem cells from chondrocytes
WO2014070796A1 (en) 2012-10-29 2014-05-08 Scripps Health Methods of transplanting chondrocytes
WO2017040630A1 (en) * 2015-08-31 2017-03-09 Cormedix Inc. Compositions for the treatment of joints
JP2022514298A (ja) * 2018-12-19 2022-02-10 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ オルガノイドおよびその組織を作製および使用するための方法
JP2022042998A (ja) * 2020-09-03 2022-03-15 学校法人東海大学 細胞シート小片、該細胞シート小片を収容した注射器、該細胞シート小片の製造方法及びその使用方法
DE102021202830A1 (de) * 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
US20230330149A1 (en) * 2022-04-14 2023-10-19 Creative Medical Technologies, Inc. Enhancement of cartilage regenerative activity of stem cell populations based on reduction of intra-articular cellular material

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5645851A (en) * 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
GB9503492D0 (en) 1995-02-22 1995-04-12 Ed Geistlich S Hne A G F R Che Chemical product
US6025327A (en) * 1997-08-08 2000-02-15 Biocell Technology, Llc Hydrolyzed collagen type II and use thereof
US6511958B1 (en) * 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US20030026786A1 (en) 1999-06-04 2003-02-06 Mark F. Pittenger Chondrogenic differentiation of human mesenchymal stem cells
EP1254670A1 (en) 2001-05-03 2002-11-06 Stichting Katholieke Universiteit Type II collagen matrices for use in cartilage engineering
US6780841B2 (en) * 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
CA2412012C (en) 2001-11-20 2011-08-02 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage
US6852331B2 (en) 2002-02-11 2005-02-08 Taipei Biotechnology Ltd., Inc. Fabrication of a cartilage implant
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
JP2008507981A (ja) 2004-07-29 2008-03-21 ステム セル イノベーションズ， インコーポレイテッド 幹細胞の分化
CA2580975A1 (en) 2004-09-24 2006-03-30 Angioblast Systems, Inc. Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof
EP2360242A1 (en) 2004-09-24 2011-08-24 Angioblast Systems, Inc. Method of enhancing proliferation and/or survival of mesenchymal procursor cells (MPC)
US20060189840A1 (en) * 2005-02-18 2006-08-24 Acorn Cardiovascular, Inc. Transmyocardial delivery of cardiac wall tension relief
ES2329636B2 (es) 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
CN101721349B (zh) * 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
KR101091028B1 (ko) * 2009-07-02 2011-12-09 아주대학교산학협력단 체내 주입형 하이드로젤 및 이의 생의학적 용도
JP5636174B2 (ja) 2009-07-10 2014-12-03 学校法人近畿大学 間葉系細胞または軟骨細胞の製法ならびに発癌性の抑制方法
US8349609B2 (en) * 2009-11-24 2013-01-08 University Of Connecticut Differentiation of human embryonic and induced pluripotent stem cells
KR100990436B1 (ko) 2009-11-30 2010-10-29 동국대학교 산학협력단 중간엽 줄기세포를 ＤＫＫ-1 또는 ｓＦＲＰ-1을 이용하여 연골세포로 분화시키는 방법
AU2011208948B2 (en) 2010-01-28 2016-05-05 The University Of Queensland Method for stem cell differentiation
EP2553086B1 (en) 2010-03-31 2017-04-19 The Scripps Research Institute Reprogramming cells
AU2011236653B2 (en) 2010-04-08 2016-10-27 The University Court Of The University Of Edinburgh Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
CN101810855B (zh) * 2010-05-20 2012-06-13 广州创尔生物技术有限公司 一种ⅱ型胶原关节软骨修复液及其制备方法
US20130122589A1 (en) 2010-07-26 2013-05-16 The University Of Manchester Targeted differentiation of stem cells
CN101934092A (zh) * 2010-08-27 2011-01-05 中国人民解放军第三军医大学第一附属医院 用于软骨再生修复的注射型软骨仿生基质材料及使用方法
KR101340458B1 (ko) * 2010-11-02 2013-12-11 서울대학교산학협력단 하이드로겔을 포함하는 연골 이식용 조성물
US8663675B2 (en) * 2010-11-18 2014-03-04 Jalaledin Ghanavi Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction
US20130336937A1 (en) 2011-03-18 2013-12-19 Institut National de la Sante et de Ia Recherche Medicale Chondrogenic differentiation media and methods for inducing chondrogenic differentiation of cells
US10724005B2 (en) 2012-09-28 2020-07-28 Scripps Health Methods of differentiating stem cells into chondrocytes
WO2014070796A1 (en) 2012-10-29 2014-05-08 Scripps Health Methods of transplanting chondrocytes
WO2014070797A1 (en) 2012-10-29 2014-05-08 Scripps Health Methods of producing pluripotent stem cells from chondrocytes
US10072242B2 (en) 2013-03-25 2018-09-11 Foundation For Biomedical Research And Innovation At Kobe Cell sorting method

Also Published As

Publication number Publication date
EP2911709B1 (en) 2018-04-18
US20150283303A1 (en) 2015-10-08
JP2015534809A (ja) 2015-12-07
US20180154046A1 (en) 2018-06-07
US9974885B2 (en) 2018-05-22
EP2911709A4 (en) 2016-06-29
WO2014070796A1 (en) 2014-05-08
US10179193B2 (en) 2019-01-15
EP2911709A1 (en) 2015-09-02
US20190143000A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
US10179193B2 (en) Methods of transplanting chondrocytes
Kessler et al. Emerging technologies and fourth generation issues in cartilage repair
US5916557A (en) Methods of repairing connective tissues
CN102614546B (zh) 用于组织修复和生物人造组织工程的细胞片及其制备方法
Hui et al. Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore
AU2004261899A1 (en) Scaffold-free self-organized 3D synthetic tissue
Yang et al. Tissue engineering strategies hold promise for the repair of articular cartilage injury
Faust et al. Cartilage tissue engineering
Dhollander et al. The use of scaffolds in the treatment of osteochondral lesions in the knee: current concepts and future trends
WO2012001124A1 (en) Mesenchymal cells and multilayer membrane for the treatment of osteochondral lesions
Chang et al. Cartilage tissue engineering
Fuentes-Mera et al. Current applications of mesenchymal stem cells for cartilage tissue engineering
Dehghani et al. Challenges for cartilage regeneration
Yu et al. Distraction osteogenesis combined with tissue-engineered cartilage in the reconstruction of condylar osteochondral defect
Lee et al. Decellularized allogeneic cartilage paste with human costal cartilage and crosslinked hyaluronic acid-carboxymethyl cellulose carrier augments microfracture for improved articular cartilage repair
Dikina et al. Scaffolds derived from ECM produced by chondrogenically induced human MSC condensates support human MSC chondrogenesis
WO1995013091A1 (en) Methods of repairing connective tissues
EP2302037A1 (en) Method for non-autologous cartilage regeneration
M Malvankar et al. An overview of the different approaches used in the development of meniscal tissue engineering
Sancho-Tello et al. Cartilage regeneration and tissue engineering
Guo et al. Engineering niches for cartilage tissue regeneration
Martin et al. Repair of osteochondral lesions
US10279075B2 (en) Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same
Akpinar et al. Future Treatment Modalities
Nugent et al. Articular Cartilage Repair, Regeneration, and Replacement

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170710

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171010

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180410

R150 Certificate of patent or registration of utility model

Ref document number: 6324395

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250